Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


St. Jude/Cambridge Heart sales

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical will market Cambridge Heart's HearTwave II microvolt t-wave alternans test to North American primary care and internal medicine physicians under an amendment to the firms' three-year marketing agreement, they announce June 18. Under the original deal, signed in March, St. Jude was only to target electrophysiologists and cardiologists for sales of the product, which is used to stratify patients by risk for implantable defibrillator need (1"The Gray Sheet" March 26, 2007, p. 8). Cambridge Heart's reps, who originally addressed the primary care and internal medicine market, will now support St. Jude's team in all physician markets...

You may also be interested in...

T-Wave Alternans ICD Screening May Gain Traction With St. Jude Pact

St. Jude Medical's endorsement of microvolt t-wave alternans testing under a co-marketing agreement with test maker Cambridge Heart will help accelerate adoption of the technology, which guides appropriate defibrillator patient selection, both companies say

Pfizer And Moderna Under Pressure To Agree Vaccine Supplies For Developing Nations

As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.

FDA Releases Final Guidance For Complex ANDA Meetings

The FDA has released final guidance on “Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA” for the industry. The guidance brings clarity and aims at facilitating product development meetings between the FDA and the ANDA applicants for complex products.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts